NYU, Rosetta Genomics, Medica Awards, Texas Institute for Genomic Medicine, UK National Stem Cell Network, Taconic, University of Albany, Lancaster University | GenomeWeb
NYU, Rosetta Genomics to Co-develop miRNA-based Lung Cancer Test
Rosetta Genomics and New York University Medical Center said this week that they plan to co-develop diagnostic tests for lung and mesothelioma cancers.
The early-detection tests will use Rosetta's technology for extracting microRNA from blood.
The tests will identify patients at risk of lung cancer due to smoking as well as those who have been exposed to asbestos fibers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.